Literature DB >> 18780873

HMGB1, a novel biomarker of inflammatory demyelinating disease: an interview with Dr. Robert A. Harris.

Helene F Rosenberg1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18780873      PMCID： PMC2567894          DOI： 10.1189/jlb.1307844

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN： 0741-5400            Impact factor:   4.962


× No keyword cloud information.
  4 in total

1.  Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion.

Authors:  Tiziana Bonaldi; Fabio Talamo; Paola Scaffidi; Denise Ferrera; Annalisa Porto; Angela Bachi; Anna Rubartelli; Alessandra Agresti; Marco E Bianchi
Journal:  EMBO J       Date:  2003-10-15       Impact factor: 11.598

2.  Screening of several H-2 congenic mouse strains identified H-2(q) mice as highly susceptible to MOG-induced EAE with minimal adjuvant requirement.

Authors:  K B Abdul-Majid; J Jirholt; C Stadelmann; A Stefferl; P Kjellén; E Wallström; R Holmdahl; H Lassmann; T Olsson; R A Harris
Journal:  J Neuroimmunol       Date:  2000-11-01       Impact factor: 3.478

3.  Induction of immunological tolerance by apoptotic cells requires caspase-dependent oxidation of high-mobility group box-1 protein.

Authors:  Hirotaka Kazama; Jean-Ehrland Ricci; John M Herndon; George Hoppe; Douglas R Green; Thomas A Ferguson
Journal:  Immunity       Date:  2008-07-18       Impact factor: 31.745

Review 4.  High-mobility group box protein 1 (HMGB1): an alarmin mediating the pathogenesis of rheumatic disease.

Authors:  David S Pisetsky; Helena Erlandsson-Harris; Ulf Andersson
Journal:  Arthritis Res Ther       Date:  2008-06-30       Impact factor: 5.156
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.